A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  International journal of fertility and menopausal studies

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8485612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• In Vitro Drug Transfer Due to Drug Retention in Human Epidermis Pretreated with Application of Marketed Estradiol Transdermal Systems

  2016cites this paper
• Transdermal menopausal hormone therapy: delivery through skin changes the rules

  2010cites this paper
• Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg

  2008cites this paper
• Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.

  2006cites this paper
• Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.

  2006cites this paper
• Drug delivery systems for hormone therapy.

  2006cites this paper
• Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch 40 and Estrapatch 60) with a twice week system.

  2005cites this paper
• Efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause.

  2004cites this paper
• Tools for making correct decisions regarding hormone therapy. part I: background and drugs.

  2004cites this paper
• Effects of Transdermal Estradiol Delivered by a Matrix Patch on Bone Density in Hysterectomized, Postmenopausal Women: A 2-year Placebo-Controlled Trial

  2002cites this paper
• A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).

  2002cites this paper
• Clinical evaluation, dose-finding and acceptability of AERODIOL, the pulsed estrogen therapy for treatment of climacteric symptoms.

  2001cites this paper
• Aerodiol versus the transdermal route: perspectives for patient preference.

  2001cites this paper
• Therapeutic value and long-term safety of pulsed estrogen therapy.

  2001cites this paper
• Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches

  2000cites this paper
• Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints.

  2000cites this paper
• Comparison of gel and patch estradiol replacement in Brazil, a tropical country.

  2000cites this paper
• Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms.

  2000cites this paper
• Endometrial safety and tolerability of AERODIOL(R) (intranasal estradiol) for 1 year.

  2000cites this paper
• Improved patient acceptability with a transdermal drug‐in‐adhesive oestradiol patch

  2000cites this paper
• Randomized Comparison of Intranasal and Transdermal Estradiol

  2000cites this paper
• Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.

  1999cites this paper
• Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group.

  1999cites this paper
• Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients

  1999cites this paper
• Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995.

  1998cites this paper
• Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.

  1997cites this paper
• New developments in topical estrogen therapy.

  1997cites this paper
• Cutaneous complications of hormonal replacement therapy.

  1997cites this paper
• Randomised crossover comparison of skin irritation with two transdermal oestradiol patches

  1997cites this paper
• Hormone replacement therapy in the aged. A state of the art review.

  1996cites this paper
• Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy.

  1996cites this paper
• Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study.

  1995cites this paper
• Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.

  1994cites this paper
• Hormone Replacement Therapy

  1994cites this paper
• Menopause LiteratureWatch

  1994cites this paper